Patients with advanced breast cancer are often accompanied by elevated platelet counts, and higher PLR suggests worse OS and DFS.[71] Moreover, PLR also showed prognostic relevance in ER + HER2-early breast cancer.[83] An association has been found between high PLR rates and TIL immunosuppressive status in triple-negative breast cancer. This evidence concerns the gene ERBB2 and breast cancer.